Copyright
©The Author(s) 2017.
World J Gastrointest Oncol. Oct 15, 2017; 9(10): 407-415
Published online Oct 15, 2017. doi: 10.4251/wjgo.v9.i10.407
Published online Oct 15, 2017. doi: 10.4251/wjgo.v9.i10.407
Study (Institution, author, yr) | n | Pancreatic cancer | Ampullary cancer | Biliary cancer | Duodenal cancer |
Johns Hopkins, United States He et al[14], 2014 | 2564 | 66% | 16% | 12% | 6% |
Academic Medical Centre, The Netherlands Tol et al[8], 2015 | 760 | 46% | 30% | 20% | 4% |
Taipei Veterans General Hospital, Taiwan Chen et al[15], 2013 | 501 | 34% | 50% | 10% | 5% |
Ohio State University, United States Hatzaras et al[24], 2010 | 346 | 72% | 23% | 5% | 0 |
Oslo University Hospital, Norway Pomianowska et al[16], 2013 | 207 | 33% | 28% | 14% | 25% |
South Australian Pathology Database, Adelaide, Australia Chandrasegaram et al[6], 2015 | 115 | 55% | 28% | 15% | 3% |
University Medical Center Groningen, The Netherlands Van Roest et al[25], 2008 | 121 | 42% | 25% | 16% | 17% |
Leeds Teaching Hospitals NHS Trust, United Kingdom Menon et al[76], 2009 | 83 | 33% | 29% | 39% | N/I |
Queen Elizabeth Hospital, Birmingham, United Kingdom Jarufe et al[28], 2004 | 251 | 53% | 35% | 12% | N/I |
University of California San Diego, United States Katz et al[17], 2004 | 120 | 62% | 26% | 8% | 4% |
- Citation: Chandrasegaram MD, Gill AJ, Samra J, Price T, Chen J, Fawcett J, Merrett ND. Ampullary cancer of intestinal origin and duodenal cancer - A logical clinical and therapeutic subgroup in periampullary cancer. World J Gastrointest Oncol 2017; 9(10): 407-415
- URL: https://www.wjgnet.com/1948-5204/full/v9/i10/407.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v9.i10.407